When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Some drugmakers to cap cost of asthma inhalers at $35 a month

   www.aol.com/news/drugmakers-cap-cost-asthma...

   Despite having health insurance, Shapland said the cost can balloon to $350 a month — a significant financial burden — depending on the severity of Jackson’s asthma.

3. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

4. Beta2-adrenergic agonist - Wikipedia

   en.wikipedia.org/wiki/Beta2-adrenergic_agonist

   Overuse of β 2 agonists and asthma treatment without proper inhaled corticosteroid use has been associated with an increased risk of asthma exacerbations and asthma-related hospitalizations. [8] The excipients, in particular sulfite , could contribute to the adverse effects.

5. If You're Living With Asthma, Here's Every Single Treatment ...

   www.aol.com/lifestyle/youre-living-asthma-heres...

   Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...

6. When the Cost of His Asthma Inhaler Went Up $500, His ... - AOL

   www.aol.com/cost-asthma-inhaler-went-500...

   The parents of Cole Schmidtknecht, 22, are suing his medical insurance company and pharmacy after he died of an asthma attack, allegedly due to the new cost of his inhaler The price of Cole's ...

7. Long-acting beta-adrenoceptor agonist - Wikipedia

   en.wikipedia.org/wiki/Long-acting_beta...

   In the United States. it was approved by the Food and Drug Administration (FDA) under the trade name Arcapta Neohaler on July 1, 2011) [12] olodaterol: approved in some European countries and Russia, and by the U.S. Food and Drug Administration (FDA) on July 31, 2014, under Striverdi Respimat [13]